Maesa balansae

Maesa balansae · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Maesa balansae is a botanical species that has gained significant attention in pharmacological research due to its diverse therapeutic potential. Recent investigations have focused specifically on the biological activities of its leaf components to address various infectious challenges. By utilizing a methanolic extract, researchers are able to isolate potent bioactive compounds present within the plant tissue. This study evaluates the efficacy of these extracts against the protozoan parasite Leishmania infantum. Understanding these interactions provides critical insights into the development of new treatments for leishmaniasis.

Quick facts
Synonyms
Not available
Common names
Not available
Family
Primulaceae
Distribution
Not available
Plant Parts
Leaf

Classification

Taxonomy

Maesa balansae is a specialized member of the kingdom Plantae. Within this vast biological realm, it belongs to the class Equisetopsida. The plant is further classified under the order Ericales, which helps define its evolutionary lineage. As a representative of the genus Maesa, it exhibits distinct botanical characteristics. Ultimately, this species is situated within the family Primulaceae.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Ericales
Family Primulaceae
Genus Maesa

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Maesa balansae is a notable plant species found throughout the diverse ecosystems of the Asia-Tropical region. Its natural range is concentrated within the lush landscapes of Indo-China, where it plays a role in the local flora. Specifically, this plant can be located across various territories, including the country of Cambodia. It also maintains a significant presence within the borders of Laos, thriving in its characteristic habitat. Finally, the distribution of Maesa balansae extends into Vietnam, completing its regional footprint.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Maesa balansae is a self-supporting plant that grows independently without the need for external structural support.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Maesa balansae is a Vietnamese medicinal plant that has demonstrated significant therapeutic potential through its unique chemical composition. Research conducted on its methanolic leaf extracts led to the identification of several bioactive triterpenoid saponins. Notably, the plant contains Maesabalide III and Maesabalide IV, which emerged as the most potent compounds during testing. These specific constituents exhibited remarkable anti-leishmanial activity against the parasite Leishmania infantum in both in vitro and in vivo models. Such findings highlight the importance of these compounds in the ongoing search for effective treatments for tropical diseases.

Conditions

Maesa balansae demonstrates potent antileishmanial activity by effectively treating Leishmania infantum through its triterpenoid saponin components. The plant's extracts specifically target and treat drug-sensitive visceral Leishmania strains in both in vitro and in vivo evaluations. Research indicates that these compounds are highly effective at treating intracellular Leishmania infantum amastigotes. Furthermore, administration of the plant extract has been shown to significantly treat liver amastigote burdens in animal models. Ultimately, Maesa balansae provides a promising means to treat liver infection by reducing parasite presence within the organ.

Preparations

Maesa balansae is prepared as a methanolic extract derived specifically from its leaves. This methanolic extract serves as the source for recovering a mixture of six oleane triterpene saponins known as maesabalides I-VI. These isolated compounds are then utilized to evaluate potent anti-leishmanial activities both in vitro and in vivo. By using the methanolic extract as a starting point, researchers successfully identified highly specific bioactive molecules against Leishmania infantum. Consequently, the preparation of Maesa balansae as a methanolic extract is a critical step in discovering new lead structures for tropical disease treatment.

Parts used

Maesa balansae is a medicinal plant native to Vietnam that holds significant pharmacological potential. Scientific investigations have focused on a methanolic extract derived specifically from the leaves of this species. Within these leaves, researchers identified a mixture of six potent oleane triterpene saponins known as maesabalides. These compounds have demonstrated remarkable in vitro and in vivo activity against the parasite Leishmania infantum. Consequently, the leaf extracts of Maesa balansae serve as promising lead structures in the ongoing search for novel antileishmanial drugs.